Surgery Partners Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surgery Partners, Inc. - SGRY

Impact · against what's priced in

Surgery Partners is being acquired by HealthSpan Partners for $23.50 per share. While the acquisition provides a clear exit value, the initiation of a legal investigation into the adequacy of the price introduces minor execution risk and potential for a higher bid, though such lawsuits are common in M&A.

SGRY+0.50

No priced-in read yet